Slides
Page 1
Second Quarter 2026 Results August 4, 2026
Page 2
Speakers Samantha Stoddard CFO Bill Christensen CEO
Page 3
Disclosures 3 Certain statements in this presentation, including our guidance and business strategies, are forward- looking statements that involve risk, uncertainty and assumptions, and are based on information as of August 4, 2026. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, you should review our Annual Report on Form 10-K, Form 10-Qs filed in 2026 and our other filings with the U.S. Securities and Exchange Commission. During this presentation, we will discuss certain non-GAAP financial measures including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted EPS, Free Cash Flow and Net Debt Leverage. A reconciliation of non-GAAP financial measures to their nearest comparable GAAP financial measures is available at the end of this presentation and our earnings release. Due to rounding, numbers presented throughout this presentation may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Page 4
Second Quarter 2026 Summary ▪ Sales of $818 million ▪ Adjusted EBITDA of $42 million ❑ 5.2% of sales ▪ Disciplined cash management ▪ Strategic review of Europe ongoing Second Quarter 2026 INVESTMENTS ARE PAYING OFF 4
Page 5
Q2 2026 Financial Results
Page 6
MARGIN EXPANSION ON SLIGHT REVENUE DECLINE Q2 2026 Financial Summary USD in Millions Net Revenue Core Revenue down (2%) driven by lower volume / mix Adjusted EBITDA Adjusted EBITDA Margin Productivity gains & cost savings driving higher earnings 6 $824 $818 Q2 2025 Q2 2026 -1% $39 $42 Q2 2025 Q2 2026 +8% 4.7% Q2 2025 5.2% Q2 2026 +50 bps
Page 7
Q2 2025 Price Volume / Mix Foreign Exchange Q2 2026 $824 $5 ($19) $9 $818 VOLUME / MIX HEADWINDS BEGINNING TO STABILIZE Q2 2026 Revenue Bridge 7 USD in Millions Core Revenue (2%) Note: Amounts do not foot due to rounding
Page 8
PRODUCTIVITY GAINS MORE THAN OFFSET PRICE / COST HEADWINDS Q2 2026 Adjusted EBITDA Bridge 8 USD in Millions Q2 2025 Price / Cost Volume / Mix Productivity SG&A / Other Income / FX Q2 2026 $39 ($29) ($5) $36 $1 $42 Adj. Margin 4.7% Adj. Margin 5.2%
Page 9
Q2 2026 Segment Results USD in Millions Segment Highlights ▪ North America revenue down (5%) year-over-year • Core revenue down (5%) • Mainly driven by lower volume ▪ Europe revenue up 8% year-over-year • Higher price, volume growth & FX tailwinds North America Q2 2026 Q2 2025 (Prior Year) Q1 2026 (Previous Quarter) Net Revenue $529 $556 $453 Adjusted EBITDA $41 $35 $4 Adjusted EBITDA margin 7.7% 6.3% 0.8% Europe Q2 2026 Q2 2025 (Prior Year) Q1 2026 (Previous Quarter) Net Revenue $289 $268 $269 Adjusted EBITDA $13 $17 $7 Adjusted EBITDA margin 4.6% 6.4% 2.6% 9
Page 10
Outlook
Page 11
Market Outlook 2026 North America Europe Low-to-Mid Single-Digit Volume Decline Stable Volumes New single-family construction Down low single-digits Repair & Remodel Down mid single-digits Multi-family & Canada Approximately Flat Residential construction Stable year-over-year Commercial projects Stable year-over-year MARKET OUTLOOK REMAINS UNCHANGED 11
Page 12
FOCUS ON CASH FLOW DISCIPLINE 2026 Updated Guidance 12 Net Revenue $3.1B to $3.2B Core Revenue Down (2%) to (5%) Adjusted EBITDA $120M to $150M Operating Cash Flow ~$10M Cap Ex ~$85M Free Cash Flow ~($75M)
Page 13
ADDITIONAL PRICE/COST HEADWINDS OFFSET BY HIGHER VOLUMES 2026 Guidance Bridge 13 Adjusted EBITDA; USD in Millions $118 $135 $85 $35 2025 EBITDA Market Volume / Mix Share Loss Volume / Mix Price / Cost Rightsizing Business / Base Productivity Transformation Carryover Other / FX 2026 EBITDA Guidance Midpoint ($25) ($20) ($50) ($8)
Page 14
North American On-Time, In-Full Rates (OTIF) SIGNIFICANT IMPROVEMENT IN DELIVERY METRICS 14 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Mar-26 Apr-26 May-26 Jun-26 Jul-26 90%
Page 15
DISCIPLINED EXECUTION DRIVING RESULTS JELD-WEN Next Steps 15 Drive Customer Service Adress Near Term Maturities
Page 16
Appendix
Page 17
Key Assumptions for 2026 Key Assumption 2026 Estimate Depreciation and Amortization ~$115 Interest Expense, net $70 to $75 Cash Taxes Paid $7 to $15 Diluted Share Count ~86 million USD in Millions ✓ Full-year EBITDA split ~35% in 1H ✓ Price / Cost negative vs 2025 ✓ Expect foreign exchange translation tailwinds due to weaker US Dollar ✓ No share repurchases, acquisitions or divestitures included in outlook 17
Page 18
Potential Impact of Tariffs USD in Millions – Tariffs as of July 21st China Cambodia, Brazil, all others Tier 2 Suppliers* 1% 11% 4% Percent of Material Costs By Country With Exposure to Tariffs ▪ Annualized tariff impact: ~$14M - Assumes 10% tariff rate through FY 2026 12% 84% Tier 1 Tier 2 No Exposure 4% 2026 North America Direct Material Costs Exposed to Tariffs * China accounts for ~65% of Tier 2 exposure 18
Page 19
Q2 2026 Net Revenue Walk 19 Q2 2026 JELD-WEN North America Europe Price 1% -% 2% Volume / Mix (3%) (5%) 3% Core Revenue Growth (2%) (5%) 5% FX 1% -% 3% Total (0.7%) (4.9%) 7.9%
Page 20
YTD 2025 Price Volume / Mix Court-Ordered Divestiture Foreign Exchange YTD 2026 $1,600 $6 ($99) ($7) $39 $1,540 LOWER VOLUME / MIX FROM MARKET HEADWINDS Q2 YTD 2026 Revenue Bridge 20 USD in Millions Core Revenue (6%) Note: Amounts do not foot due to rounding
Page 21
PRICE / COST HEADWINDS FROM COMPETITIVE MARKET Q2 YTD 2026 Adjusted EBITDA Bridge 21 USD in Millions YTD 2025 Price / Cost Volume / Mix Productivity SG&A / Other Income YTD 2026 $61 ($51) ($27) $58 $7 $48 Adj. Margin 3.8% Adj. Margin 3.1%
Page 22
Balance Sheet and Cash Flow USD in Millions Cash Flow (YTD) Q2 2026 Q2 2025 Net cash used in operating activities ($100) ($49) Capital Expenditures(1) ($45) ($76) Free Cash Flow(2) ($145) ($125) Balance Sheet June 27, 2026 December 31, 2025 Total Debt $1,244 $1,173 Cash $57 $136 Net Debt(3) $1,187 $1,037 Divided by trailing twelve months Adjusted EBITDA(4) $106 $118 Net Debt Leverage(3) 11.3x 8.8x Liquidity(5) $309 $485 (1) Includes purchases of property, equipment, and intangible assets. (2) Free Cash Flow is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Free Cash Flow, refer to the Q2 2026 earnings release. (3) Net Debt and Net Debt Leverage are financial measures that are not calculated in accordance with GAAP. For a discussion of our presentation of Net Debt Leverage refer to the Q2 2026 earnings release. (4) Trailing twelve months Adjusted EBITDA from continuing operations for both periods. Adjusted EBITDA from continuing operations is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA from continuing operations, refer to the Q2 2026 earnings release. Additionally, refer to the calculation of trailing twelve months Adjusted EBITDA from continuing operations included later in this presentation. (5) Liquidity includes cash and cash equivalents, as well as availability from undrawn committed credit facilities. 22
Page 23
Adjusted Net Loss From Continuing Operations Reconciliation (1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. (2) Other special items not core to ongoing business activity include: (i) for the three and six months ended June 27, 2026, a $2.7 million impairment charge in our North America reporting unit related to windows manufacturing technology and a $1.8 million impairment charge related to logistics technology, each of which was determined to have no future use, and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture; and (ii) for the six months ended June 27, 2026, a $3.1 million impairment charge recognized in connection with the Company’s North America equipment capacity optimization review, $2.0 million related to post-production expenses for closed facilities in North America and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture. (3) Except for non-deductible goodwill impairments, adjustments to net loss from continuing operations and adjusted net loss per share from continuing operations are tax-effected using the applicable jurisdictional statutory tax rate. (4) Tax special items for the three and six months ended June 27, 2026, were primarily driven by tax expense attributable to domestic share-based compensation of $0.5 million and $3.1 million, respectively, fully offset by tax benefit due to the valuation allowance recorded against our U.S. tax attributes of $0.5 million and $3.1 million, respectively and tax expense due to changes in UTPs from ongoing audits of $0.6 million and $1.1 million, respectively. Tax special items for the six months ended June 28, 2025, were primarily driven by valuation expense recorded against our U.S. tax attributes of $14.2 million. For the three and six months ended June 28, 2025, tax expense attributable to share-based compensation was $0.6 million and $1.8 million, respectively. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. USD in Millions Three Months Ended Six Months Ended (amounts in millions) June 27, 2026 June 28, 2025 June 27, 2026 June 28, 2025 Loss from continuing operations, net of tax $ (31.5) $ (22.3) $ (108.4) $ (212.4) Special items:(1) Net legal and professional expenses and settlements 2.8 8.6 15.6 20.5 Goodwill impairment — — — 137.7 Restructuring and asset-related charges, net 4.1 8.8 6.1 23.4 M&A related costs, net 3.4 0.1 10.9 (0.5) Net gain on sale of business, property, and equipment — (2.2) — (2.8) Loss on extinguishment and refinancing of debt — — — 0.2 Share-based compensation expense 3.7 4.4 7.4 7.7 Other special items(2) 7.8 1.1 14.8 3.9 Tax impact of special items(3) — (3.6) — (10.6) Tax special items(4) 0.6 1.6 1.1 15.3 Adjusted Net Loss from continuing operations $ (9.1) $ (3.4) $ (52.4) $ (17.6) 23
Page 24
Adjusted Net Loss Per Share From Continuing Operations Reconciliation Three Months Ended Six Months Ended June 27, 2026 June 28, 2025 June 27, 2026 June 28, 2025 Diluted loss per share from continuing operations $ (0.37) $ (0.26) $ (1.26) $ (2.50) Special items:(1) Net legal and professional expenses and settlements 0.03 0.10 0.18 0.24 Goodwill impairment — — — 1.62 Restructuring and asset-related charges, net 0.05 0.10 0.07 0.27 M&A related costs, net 0.04 — 0.13 (0.01) Net gain on sale of business, property, and equipment — (0.03) — (0.03) Share-based compensation expense 0.04 0.05 0.09 0.09 Other special items(2) 0.09 0.01 0.17 0.05 Tax impact of special items(3) — (0.04) — (0.12) Tax special items(4) 0.01 0.02 0.01 0.18 Adjusted Net Loss per share from continuing operations $ (0.11) $ (0.04) $ (0.61) $ (0.21) Weighted average basic shares 86,384,988 85,298,517 86,100,779 85,111,100 24 (1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed above. (2) Other special items not core to ongoing business activity include: (i) for the three and six months ended June 27, 2026, a $2.7 million impairment charge in our North America reporting unit related to windows manufacturing technology and a $1.8 million impairment charge related to logistics technology, each of which was determined to have no future use, and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture; and (ii) for the six months ended June 27, 2026, a $3.1 million impairment charge recognized in connection with the Company’s North America equipment capacity optimization review, $2.0 million related to post-production expenses for closed facilities in North America and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture. (3) Except for non-deductible goodwill impairments, adjustments to net loss from continuing operations and adjusted net loss per share from continuing operations are tax-effected using the applicable jurisdictional statutory tax rate. (4) Tax special items for the three and six months ended June 27, 2026, were primarily driven by tax expense attributable to domestic share-based compensation of $0.5 million and $3.1 million, respectively, fully offset by tax benefit due to the valuation allowance recorded against our U.S. tax attributes of $0.5 million and $3.1 million, respectively and tax expense due to changes in UTPs from ongoing audits of $0.6 million and $1.1 million, respectively. Tax special items for the six months ended June 28, 2025, were primarily driven by valuation expense recorded against our U.S. tax attributes of $14.2 million. For the three and six months ended June 28, 2025, tax expense attributable to share-based compensation was $0.6 million and $1.8 million, respectively. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Page 25
Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions (1) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $1.5 million, and $4.1 million in the three and six months ended June 27, 2026, respectively, and $8.1 million and $19.3 million in the three and six months ended June 28, 2025, respectively. These expenses primarily relate to discrete project -based consulting fees that directly support the Company’s tran sformation journey and are not expected to represent normal, recurring operating expenses. These projects include the central ization of human resources processes, North America supply chain network optimization strategy, and other projects related to our transformation journey . These expenses also include $0.4 million and $2.5 million for the three and six months ended June 28, 2025, respectively, related to the engagement of a transformation consultant for a period spanning from the third quarter of 2023 through April 2025. Additionally, net legal an d professional expenses and settlements include $0.3 million and $9.6 million in the three and six months ended June 27, 2026, respectively, and $(0.6) million and a nominal amount in the three and six months ended June 28, 2025, respectively, relating to litigation of historical legal matt ers. (2) Goodwill impairment consists of a prior year goodwill impairment charge associated with our North America reporting unit. (3) Restructuring and asset-related charges, net represents severance, accelerated depreciation and amortization, equipment relocati on and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to ch arges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (4) Product and inventory-related charges represent charges associated with announced facility closures, including product -related cash charges recorded as a reduction of net revenues and inventory and other product -related non-cash charges recorded in cost of sales. These amounts are excluded from Adjusted EBITDA from continuing operations. (5) M&A related costs, net consist of legal and professional expenses related to strategic initiatives and the court -ordered divestiture of Towanda. (6) Net gain on sale of business, property, and equipment in the three months ended June 28, 2025, primarily relates to the sale of property and equipment in Marion, North Carolina. Net gain on sale of business, property and equipment in the six months ende d June 28, 2025, primarily relates to the court-ordered divestiture of Towanda and the sale of property and equipment in Marion, North Carolina. (7) Loss on extinguishment and refinancing of debt consists of $0.2 million in the six months ended June 28, 2025, associated with an amendment of our ABL Facility. (8) Share-based compensation expense represents equity-based compensation expense related to the issuance of share -based awards. (9) Other special items not core to ongoing business activity include: ( i) for the three and six months ended June 27, 2026, a $2.7 million impairment charge in our North America reporting unit related to windows manufacturing technology and a $1.8 million impairment charge related to logistics technology, each of which was determined to have no future use, and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture; and (ii) for the six months ended June 27, 2026, a $3.1 million impairment charge recognized in connection with the Company’s North America equipment capacity optimization review, $2.0 million related to post-production expenses for closed facilities in North America and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended Six Months Ended (amounts in millions) June 27, 2026 June 28, 2025 June 27, 2026 June 28, 2025 Loss from continuing operations, net of tax $ (31.5) $ (22.3) $ (108.4) $ (212.4) Income tax expense (benefit) 4.6 (3.5) 8.0 (2.9) Depreciation and amortization 29.0 27.4 58.3 54.7 Interest expense, net 18.4 16.5 35.6 31.4 Special items: Net legal and professional expenses and settlements(1) 2.8 8.6 15.6 20.5 Goodwill impairment(2) — — — 137.7 Restructuring and asset-related charges, net(3)(4) 4.1 8.8 6.1 23.4 M&A related costs, net(5) 3.4 0.1 10.9 (0.5) Net gain on sale of business, property, and equipment(6) — (2.2) — (2.8) Loss on extinguishment and refinancing of debt(7) — — — 0.2 Share-based compensation expense(8) 3.7 4.4 7.4 7.7 Other special items(9) 7.8 1.1 14.8 3.9 Adjusted EBITDA from continuing operations $ 42.3 $ 39.0 $ 48.4 $ 60.9 25
Page 26
Q2 2026 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation (1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. (2) North America other special items include impairment charges of $2.7 million related to windows manufacturing technology, and $1.8 million related to logistics technology, each of which was determined to have no future use, and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended June 27, 2026 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 26.9 $ (3.4) $ (55.0) $ (31.5) Income tax (benefit) expense (12.0) 3.8 12.8 4.6 Depreciation and amortization 18.4 8.2 2.4 29.0 Interest expense, net 0.1 1.0 17.3 18.4 Special items:(1) Net legal and professional expenses and settlements 0.2 0.5 2.2 2.8 Restructuring and asset-related charges, net 1.6 2.1 0.4 4.1 M&A related costs, net — — 3.4 3.4 Share-based compensation expense 0.7 0.4 2.7 3.7 Other special items(2) 4.8 0.7 2.4 7.8 Adjusted EBITDA from continuing operations $ 40.7 $ 13.2 $ (11.6) $ 42.3 26 USD in Millions
Page 27
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended June 28, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 8.9 $ (4.0) $ (27.3) $ (22.3) Income tax expense (benefit) 5.3 4.5 (13.2) (3.5) Depreciation and amortization 16.8 8.2 2.4 27.4 Interest (income) expense, net (0.6) 1.6 15.5 16.5 Special items:(1) Net legal and professional expenses and settlements 0.8 1.7 6.2 8.6 Restructuring and asset-related charges, net 4.4 4.4 — 8.8 M&A related costs, net — — 0.1 0.1 Net gain on sale of business, property and equipment (2.2) — — (2.2) Share-based compensation expense 1.0 0.6 2.9 4.4 Other special items 0.3 0.1 0.7 1.1 Adjusted EBITDA from continuing operations $ 34.7 $ 17.0 $ (12.8) $ 39.0 27 Q2 2025 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions
Page 28
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed in the Q1 2026 earnings presentation. (2) North America other special items include an impairment charge of $3.1 million as a result of reviews performed in connection with our North America equipment capacity optimization. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended March 28, 2026 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss, net of tax $ (35.0) $ (10.1) $ (31.8) $ (76.8) Income tax expense (benefit) 13.5 2.8 (13.0) 3.4 Depreciation and amortization 18.8 8.4 2.2 29.4 Interest (income) expense, net (0.5) 0.8 16.9 17.2 Special items:(1) Net legal and professional expenses and settlements 0.2 2.0 10.6 12.8 Restructuring and asset-related charges, net 0.8 1.2 — 2.0 M&A related costs, net — — 7.6 7.6 Share-based compensation expense 0.6 0.5 2.5 3.7 Other special items(2) 5.1 1.5 0.4 7.0 Adjusted EBITDA $ 3.6 $ 7.1 $ (4.6) $ 6.1 28 USD in Millions Q1 2026 QTD Segment Adjusted EBITDA Reconciliation
Page 29
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. (2) North America other special items include impairment charges of $3.1 million recognized in connection with the Company’s North America equipment capacity optimization review, $2.7 million related to windows manufacturing technology, and $1.8 million related to logistics technology, each of which was determined to have no future use, as well as $2.0 million related to post-production expenses for closed facilities in North America and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Six Months Ended June 27, 2026 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss from continuing operations, net of tax $ (8.1) $ (13.5) $ (86.7) $ (108.4) Income tax expense (benefit) 1.6 6.6 (0.2) 8.0 Depreciation and amortization 37.2 16.6 4.5 58.3 Interest (income) expense, net (0.4) 1.8 34.2 35.6 Special items:(1) Net legal and professional expenses and settlements 0.4 2.5 12.8 15.6 Restructuring and asset-related charges, net 2.4 3.2 0.4 6.1 M&A related costs, net — — 10.9 10.9 Share-based compensation expense 1.3 0.9 5.2 7.4 Other special items(2) 9.9 2.2 2.8 14.8 Adjusted EBITDA from continuing operations $ 44.3 $ 20.3 $ (16.1) $ 48.4 29 USD in Millions Q2 2026 YTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 30
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Six Months Ended June 28, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss from continuing operations, net of tax $ (152.3) $ (7.4) $ (52.7) $ (212.4) Income tax expense (benefit) 14.6 6.4 (23.9) (2.9) Depreciation and amortization 34.1 15.8 4.8 54.7 Interest (income) expense, net (1.2) 1.6 31.0 31.4 Special items:(1) Net legal and professional expenses and settlements 1.5 2.7 16.3 20.5 Goodwill impairment 137.7 — — 137.7 Restructuring and asset-related charges, net 15.1 7.6 0.7 23.4 M&A related income, net — — (0.5) (0.5) Net gain on sale of business, property, and equipment (2.8) — — (2.8) Loss on extinguishment and refinancing of debt — — 0.2 0.2 Share-based compensation expense 1.5 1.0 5.1 7.7 Other special items 2.1 0.1 1.8 3.9 Adjusted EBITDA from continuing operations $ 50.3 $ 27.7 $ (17.1) $ 60.9 30 USD in Millions Q2 2025 YTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 31
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Trailing Twelve Months Ended (amounts in millions) June 27, 2026 December 31, 2025 Loss from continuing operations, net of tax $ (518.2) $ (622.2) Income tax expense 158.8 147.9 Depreciation and amortization 116.0 112.4 Interest expense, net 71.3 67.2 Special items:(1) Net legal and professional expenses and settlements 26.5 31.5 Goodwill impairment 196.9 334.6 Restructuring and asset-related charges, net 27.2 44.5 M&A related costs, net 20.5 9.1 Net gain on sale of business, property and equipment (34.3) (37.1) Loss on extinguishment and refinancing of debt — 0.2 Share-based compensation expense 14.8 15.0 Pension settlement charge 6.6 6.6 Other special items 19.3 8.4 Adjusted EBITDA from continuing operations $ 105.5 $ 118.0 31 Q2 2026 TTM Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions